Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for Right Heart Function in COPD at High Altitude
NCT04915365Phase 3Unknown
- Sponsor
- University of Zurich
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide in Altitude sickness (AMS), sponsored by University of Zurich. Status: unknown.
02
Drugs
acetazolamide
03
Conditions
Altitude sickness (AMS)
Beyond the preview
Go deeper on NCT04915365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04915365.